Institut Bordet - Retour à la page d'accueil
en
I want to donate to research

Fabrice Journé

Department : Laboratory of Oncology and Experimental Surgery (LOCE)
 
fabrice.journe [at] bordet.be

Publications

Survival and treatment outcome of head and neck cancer patients with pulmonary oligometastases.

Authors : Lardinois I, Dequanter D, Lechien JR, Bouland C, Javadian R, Rodriguez A, Loeb I, Journe F, Saussez S
Year : 2021
Journal : Clin Otolaryngol

Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.

Authors : Sabbah M, Krayem M, Najem A, Sales F, Miller W, Del Rincon S, Awada A, Ghanem GE, Journe F
Year : 2021
Journal : Mol Cancer Res

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates anti-tumor immune responses.

Authors : Huang F, Goncalves C, Bartish M, Rémy-Sarrazin J, Issa ME, Cordeiro B, Guo Q, Emond A, Attias M, Yang W, Plourde D, Su J, Gimeno MG, Zhan Y, Galán A, Rzymski T, Mazan M, Masiejczyk M, Faber J, Khoury E, Benoit A, Gagnon N, Dankort D, Journe F, Ghanem G, Krawczyk CM, Saragovi HU, Piccirillo CA, Sonenberg N, Topisirovic I, Rudd CE, Miller WH Jr, Del Rincón SV
Year : 2021
Journal : J Clin Invest

RTK Inhibitors in Melanoma: From Bench to Bedside.

Authors : Sabbah M, Najem A, Krayem M, Awada A, Journe F, Ghanem G
Year : 2021
Journal : Cancers (Basel)

New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer.

Authors : Gheysen L, Soumoy L, Trelcat A, Verset L, Journe F, Saussez S
Year : 2021
Journal : Cells

More publications »

Follow us!

Youtube

Delivery of the first MRI-Linac in Belgium to the Radiotherapy Department of the New Jules Bordet Institute!

The very latest radiotherapy equipment representing one more step on the road to perfecting our cancer treatment and the precision of our patient care.